Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Eller

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Plos Pathogens|July 28, 2018
Evolution of HIV-1 within untreated individuals and at the population scale in UgandaJayna Raghwani, Andrew D Redd, Andrew F Longosz, et al.
The Journal of Infectious Diseases|December 11, 2014
Cellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndromeDavid B Meya, Samuel Okurut, Godfrey Zziwa, et al.
Ebiomedicine|October 4, 2023
Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccineYifan Li, Mélanie Merbah, Suzanne Wollen-Roberts, et al.
Vaccine|October 9, 2007
Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy UgandansMichael A Eller, Leigh Anne Eller, Marc S Opollo, et al.
Science Translational Medicine|August 30, 2019
A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trialsPhilip K Ehrenberg, Shida Shangguan, Biju Issac, et al.
The Journal of Infectious Diseases|November 19, 2014
HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation LevelsMichael A Eller, Marc S Opollo, Michelle Liu, et al.
Plos Pathogens|August 4, 2016
Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV InfectionKorey R Demers, George Makedonas, Marcus Buggert, et al.
The Journal of Infectious Diseases|October 29, 2002
Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cellsMary A Marovich, John R Mascola, Michael A Eller, et al.
Ebiomedicine|July 29, 2022
Dissecting drivers of immune activation in chronic HIV-1 infectionHendrik Streeck, Alvino Maestri, Daniel Habermann, et al.
Journal of Virology|February 5, 2016
Expansion of Inefficient HIV-Specific CD8 T Cells during Acute InfectionMichael A Eller, Nilu Goonetilleke, Boonrat Tassaneetrithep, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Plos Pathogens|July 28, 2018
Evolution of HIV-1 within untreated individuals and at the population scale in UgandaJayna Raghwani, Andrew D Redd, Andrew F Longosz, et al.
The Journal of Infectious Diseases|December 11, 2014
Cellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndromeDavid B Meya, Samuel Okurut, Godfrey Zziwa, et al.
Ebiomedicine|October 4, 2023
Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccineYifan Li, Mélanie Merbah, Suzanne Wollen-Roberts, et al.
Vaccine|October 9, 2007
Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy UgandansMichael A Eller, Leigh Anne Eller, Marc S Opollo, et al.
Science Translational Medicine|August 30, 2019
A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trialsPhilip K Ehrenberg, Shida Shangguan, Biju Issac, et al.
The Journal of Infectious Diseases|November 19, 2014
HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation LevelsMichael A Eller, Marc S Opollo, Michelle Liu, et al.
Plos Pathogens|August 4, 2016
Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV InfectionKorey R Demers, George Makedonas, Marcus Buggert, et al.
The Journal of Infectious Diseases|October 29, 2002
Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cellsMary A Marovich, John R Mascola, Michael A Eller, et al.
Ebiomedicine|July 29, 2022
Dissecting drivers of immune activation in chronic HIV-1 infectionHendrik Streeck, Alvino Maestri, Daniel Habermann, et al.
Journal of Virology|February 5, 2016
Expansion of Inefficient HIV-Specific CD8 T Cells during Acute InfectionMichael A Eller, Nilu Goonetilleke, Boonrat Tassaneetrithep, et al.
Pageof 9